Goyal RK, Zhang J, Davis KL, Kaufman PA. Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior PI3K inhibitor therapy for metastatic breast cancer. Poster presented at the 2022 San Antonio Breast Cancer Symposium (SABCS); December 6, 2022. San Antonio, TX.
Hudson KE, Arnold Egloff SA, Goyal RK, Cai B, Caro N, Frost M, Darrien Ansquer V, Davis KL. Real-world assessment of clinical outcomes associated with immunotherapy and chemotherapy in patients with non–small cell lung cancer with brain metastases and MET exon 14 skipping mutations treated in US community centers. Poster presented at the 2022 North America Conference on Lung Cancer; September 25, 2022. Chicago, IL.
Diez-Campelo M, Yucel A, Goyal R, Parikh R, Dhuliawala S, Jimenez M, Sluga-O'Callaghan M, Hughes C, Tang D, Germing U. Systemic therapy utilization and hematologic outcomes in lower-risk myelodysplastic syndromes (LR-MDS): findings from a real-world medical record review study in the US, UK, and Europe (EU). Poster presented at the 2022 European Hematology Association Hybrid Congress; June 10, 2022. Vienna, Austria.
Paik PK, Goyal RK, Cai B, Price M, Davis K, Derrien Ansquer V, Caro N, Saliba TR. Real-world assessment of clinical outcomes in NSCLC patients with MET exon 14 skipping mutation and brain metastases (BM) treated with capmatinib. Poster presented at the ASCO 2022 Annual Meeting; June 2022. Chicago, IL. [abstract] J Clin Oncol. 2022 Jun 2; 40(16_suppl):e21171. doi: 10.1200/JCO.2022.40.16_suppl.e21171
Ardeshirrouhanifard S, An H, Goyal RK, Raji MA, Segal JB, Alexander GC, Mehta HB. Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016. Pharmacotherapy. 2022 May;42(5):375-86. doi: 10.1002/phar.2679
Goyal RK, Zhang J, Dhuliawala S, Slug-O'Callaghan M, Kaufman PA. Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for metastatic breast cancer. Poster presented at the 39th Annual Miami Breast Cancer Conference; March 3, 2022. Miami Beach, FL.